155 related articles for article (PubMed ID: 36153916)
1. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2021 Jun; ():. PubMed ID: 34154847
[TBL] [Abstract][Full Text] [Related]
3. Sodium Correction Practice and Clinical Outcomes in Profound Hyponatremia.
Geoghegan P; Harrison AM; Thongprayoon C; Kashyap R; Ahmed A; Dong Y; Rabinstein AA; Kashani KB; Gajic O
Mayo Clin Proc; 2015 Oct; 90(10):1348-55. PubMed ID: 26434962
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
[TBL] [Abstract][Full Text] [Related]
5. Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A; Refardt JC; Christ-Crain M; Zandbergen AAM; Hoorn EJ
Eur J Endocrinol; 2023 Mar; 188(3):322-330. PubMed ID: 36881992
[TBL] [Abstract][Full Text] [Related]
6. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
[TBL] [Abstract][Full Text] [Related]
7. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
[TBL] [Abstract][Full Text] [Related]
8. The impact of the correction of hyponatremia during hospital admission on the prognosis of SARS-CoV-2 infection.
de La Flor JC; Gomez-Berrocal A; Marschall A; Valga F; Linares T; Albarracin C; Ruiz E; Gallegos G; Gómez A; de Los Santos A; Rodeles M
Med Clin (Barc); 2022 Jul; 159(1):12-18. PubMed ID: 34635318
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department.
Sumi H; Imai N; Shibagaki Y
Clin Exp Nephrol; 2022 Nov; 26(11):1086-1091. PubMed ID: 35870090
[TBL] [Abstract][Full Text] [Related]
10. NaCl 3% Bolus Therapy as Emergency Treatment for Severe Hyponatremia: Comparison of 100 mL vs 250 mL.
Massop K; Haverkort DA; Bech AP; de Boer H
J Clin Endocrinol Metab; 2023 Jul; 108(8):e521-e526. PubMed ID: 36808420
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia in ICU.
Pillai KS; Trivedi TH; Moulick ND
J Assoc Physicians India; 2018 May; 66(5):48-52. PubMed ID: 30477055
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms, risks, and new treatment options for hyponatremia.
Ghali JK
Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
[TBL] [Abstract][Full Text] [Related]
14. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes.
Doshi SM; Shah P; Lei X; Lahoti A; Salahudeen AK
Am J Kidney Dis; 2012 Feb; 59(2):222-8. PubMed ID: 22001181
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Hyponatremia: A Review.
Adrogué HJ; Tucker BM; Madias NE
JAMA; 2022 Jul; 328(3):280-291. PubMed ID: 35852524
[TBL] [Abstract][Full Text] [Related]
16. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection.
Mohmand HK; Issa D; Ahmad Z; Cappuccio JD; Kouides RW; Sterns RH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1110-7. PubMed ID: 17913972
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
19. [Osmotic demyelination syndrome and overly rapid correction of hyponatremia].
Grosjean A; Thieffry C; Marti C
Rev Med Suisse; 2022 Oct; 18(801):2012-2018. PubMed ID: 36314091
[TBL] [Abstract][Full Text] [Related]
20. Ten pitfalls in the proper management of patients with hyponatremia.
Filippatos TD; Liamis G; Elisaf MS
Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
